LGMN and Alzheimer disease: AD-associated gut microbiota (characterized by enrichment in Bacteroides spp.) can upregulate pro-inflammatory polyunsaturated fatty acid metabolism through activation of the C/EBPβ/AEP pathway, enhancing microglial activation and aggravating neuroinflammation, thereby promoting AD pathology and cognitive impairment (Chen et al., 2022a).